A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.

Neurohr, C., Kneidinger, N., Ghiani, A., Monforte, V., Knoop, C., Jaksch, P., Parmar, J., Ussetti, P., Sole, A., Müller-Quernheim, J., Kessler, R., Wirtz, H., Boerner, G., Denk, O., Prante Fernandes, S. & Behr, J. (2022).

American Journal of Transplantation 2022;22:222–229.
 

Read the publication